Akademisyen
SEMA AKINCI
PROFESÖR
ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 98
- Proje 0
- Kitap 0
- Bildiri 134
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
3
Q2
22
Q3
28
Q4
9
WoS (JCR)
Q1
1
Q2
7
Q3
31
Q4
15
TR Index
20
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
3
Ort. yüzdelik
46.7%
Üst %1 payı
0.0%
Üst %10 payı
4.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2024 INTERVENTIONAL PROCEDURE IN HEMOPHILIA A PATIENT WITH EXTENDED HALF-LIFE FACTOR THERAPY- CIRCUMCISION- CASE REPORT YÖKSİS SJR Q3 JCR Q3 OpenAlex 38.2%
- 2023 Oral iron absorption test: myth or reality? YÖKSİS SJR Q4 OpenAlex 55.7%
- 2023 Comparison of low dose cytosine arabinoside, azacitidine and azacitidine venetoclax combination treatment as remission induction in elderly acute myeloid leukemia patients YÖKSİS TR Index OpenAlex 32.0%
- 2023 Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia YÖKSİS SJR Q3 OpenAlex 61.5%
- 2023 Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data YÖKSİS SJR Q1 JCR Q2 OpenAlex 13.4%
- 2022 Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 58.1%
- 2022 COVID-19 Disease in Patients with Hematological Disease-Single Center Data YÖKSİS OpenAlex 7.9%
- 2022 Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 57.3%
- 2021 Massive platelet clumping on peripheral blood smear, Pseudothrombocytopenia in a patient with COVID 19 YÖKSİS TR Index SJR Q3 JCR Q2 OpenAlex 69.4%
- 2020 The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma YÖKSİS SJR Q2 JCR Q3 OpenAlex 77.6%
- 2020 VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience YÖKSİS SJR Q3 OpenAlex 48.5%
- 2020 Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera YÖKSİS SJR Q3 JCR Q4 OpenAlex 41.0%
- 2019 Thiol-disulphide homeostasis in essential thrombocythemia patients YÖKSİS SJR Q3 JCR Q3 OpenAlex 56.8%
- 2019 Thiol – disulphide homeostasis in polycythemia vera - Polistemia vera olgularında thiol-disülfid homeostasis YÖKSİS OpenAlex 7.4%
- 2019 The least incompatible crossmatch red blood cell transfusion by biological compatibility test YÖKSİS OpenAlex 55.0%
- 2019 Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic? YÖKSİS SJR Q4 JCR Q4 OpenAlex 9.5%
- 2019 Single-center experience: comparison of reduced intensive chemotherapy and low-dose cytarabine treatment as remission induction in older age aml cases YÖKSİS SJR Q2 JCR Q3 OpenAlex 12.7%
- 2019 PB2171 THE COMPARISON OF THE RELATIONSHIP BETWEEN POLYNEUROPATHY FREQUENCY AND CLINICAL AND LABORATORY FINDINGS IN MULTIPLE MYELOMA CASES YÖKSİS SJR Q3 JCR Q1
- 2019 Effect of Treatment on the Muscle Mass and Response to Therapy in Hodgkin\u2019s Lymphoma YÖKSİS TR Index OpenAlex 4.4%
- 2018 The Place of Interventional Hematologic Investigations in Unknown Fever Etiology YÖKSİS TR Index SJR Q4 OpenAlex 17.3%